Get startedLog in
    Picture of Tessera Defense and Homeland Security logo

    HLSQ — Tessera Defense and Homeland Security News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: BiomX Announces Discontinuation Of Phase 2b Bx004 Trial Following Internal Review

    Picture of Tessera Defense and Homeland Security logoTessera Defense and Homeland Security
    08/12/2025 12:34
    Dec 8 (Reuters) - Biomx Inc PHGE.A:

BIOMX ANNOUNCES DISCONTINUATION OF PHASE 2B BX004 TRIAL FOLLOWING INTERNAL REVIEW

BIOMX INC - PLANS COST-CUTTING MEASURES INCLUDING WORKFORCE REDUCTION

BIOMX INC - DECISION FOLLOWS SAFETY REVIEW BY INDEPENDENT DMC

BIOMX INC - SEES POTENTIAL IN BX011 FOR S. AUREUS INFECTIONS

Source text: ID:nGNX8KfLKK

Further company coverage: PHGE.A

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Tessera Defense and Homeland Security

    See all news